Publications - Sujay A . Vora, M.D.

Back to Research Profile

1. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer 2009 Aug 10. [Epub ahead of print]
   View PubMed
2. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy 2009 Jul-Sep; 8(3):309-12.
   View PubMed
3. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy 2009 Jul-Sep; 8(3):309-12. Epub 2009 Feb 12.
   View PubMed
4. Lyons MK, Vora SA. Brain tumors: current issues in diagnosis and management. Semin Neurol 2007 Sep; 27(4):312-24.
   View PubMed
5. Lyons MK, Vora SA. Brain tumors: current issues in diagnosis and management. Semin Neurol 2007 Sep; 27(4):312-24.
   View PubMed
6. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29.
   View PubMed
7. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2007 Jul 15; 68(4):1053-8.
   View PubMed
8. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007 Apr 1; 67(5):1318-22.
   View PubMed
9. Vora SA, Wong WW, Schild SE, Ezzell G, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low dose 3-dimensional conformal radiation therapy or high dose IMRT for localized prostate cancer. Int J Radiat Oncol Biol Phys (in press) 2007.
10. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005 Aug 1; 62(5):1432-7.
11. Schwartz DJ, Schild SE, Wong WW, Vora SA. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005 Jan 1; 61(1):60-3.
    View PubMed
12. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology 2004 Oct; 64(4):760-4.
    View PubMed
13. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004 Sep 1; 60(1):24-9.
    View PubMed
14. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol 2004 Aug; 27(4):389-94.
    View PubMed
15. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys 2004 Apr 1; 58(5):1530-5.
    View PubMed
16. Vora SA, Garner SL. Role of radiation therapy for facial skin cancers. Clin Plast Surg 2004 Jan; 31(1):33-8.
    View PubMed
17. Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC). Med Dosim 2004; 29(3):196-203.
    View PubMed
18. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol 2003 Nov; 170(5):1833-7.
    View PubMed
19. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002 Nov 1; 54(3):729-34.
    View PubMed
20. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2002 Aug 1; 53(5):1130-8.
    View PubMed
21. Safran H, Moore T, Iannitti D, Dipetrillo T, Akerman P, Cioffi W, Harrington D, Quirk D, Rathore R, Cruff D, Vakharia J, Vora SA, Savarese D, Wanebo H. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. International Journal Radiation Oncology Biol Physics 2001; 49(5):1275-9.
22. Vora SA, Daly BD, Blaszkowsky L, McGrath JJ, Bankoff M, Supran S, Dipetrillo TA. High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 2000 Nov 1; 89(9):1946-52.
    View PubMed
23. Vora SA, Wazer DE, Homer MJ. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy. Radiology 1997 Jun; 203(3):667-71.
    View PubMed
24. Mangan DF, Novak MJ, Vora SA, Mourad J, Kriger PS. Lectinlike interactions of Fusobacterium nucleatum with human neutrophils. Infection & Immunity 1989 Nov; 57(11):3601-11.
    View PubMed
25. Mangan DF, Novak MJ, Vora SA, et al. Lectin-like interactions of fusobacterium nucleatum with human neutrophils. Infection and Immunity 1989; 57(11):3601-11.
    View PubMed
26. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of Phase III Double-Blind, Placebo-Controlled Trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007 Apr 1; 67(5):1318-22.
    View PubMed